This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Investigators from multiple institutions conducted a study to assess the effects of prenatal selective serotonin reuptake inhibitor (SSRI) exposure and brain development in young infants. For the study, MRI findings of the brains of young infants exposed to SSRI in utero were compared to those unexposed to these drugs, including both those whose mothers had prenatal depression (PMD) or were healthy controls (HC). The mothers of study infants were enrolled between 19 and 39 weeks’ gestation and were classified as being in the SSRI group based on self-report of SSRI use at some point during pregnancy. Those …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Related Articles
Cited By...
- No citing articles found.